Sign Up to Receive Your Personalised Learning Resources
Start Learning
PARP inhibitors as first-line maintenance therapy in ovarian cancer: How can data from ESGO 2022 guide clinical practice?
Jorge Cortes, ASH 2022: New agents in relapsed or refractory acute myeloid leukaemia
Tafasitamab + Lenalidomide in Addition to R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma: An expert interview with Umberto Vitolo
Judy Boughey, SABCS 2022: Breast conservation therapy in patients with multiple ipsilateral breast cancer – The ACOSOG (Alliance) Z11102 trial
Pamela Kearns: Leading SIOP Europe during the COVID-19 Pandemic
Trastuzumab Deruxtecan for the Treatment of HER2-positive Breast Cancer
PARP inhibitors in prostate cancer: New combinations, new possibilities
Misako Nagasaka, ELCC 2022: Results of the TRUST-II Study
Use of Circulating Tumour DNA to Assess Minimal Residual Disease in Gastrointestinal Cancers
Current and emerging treatments for chronic myeloid leukemia: What have we learnt from EHA Hybrid Conference 2022?
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
Exploring the latest advances in first-line treatment of ES-SCLC: Translating the data to clinical practice
View
Jean-Pascal Machiels, ESMO 2022: Highlights in head and neck cancer
View
Shaji Kumar, ASH 2022: Updated efficacy analysis from the phase III MAIA study in newly-diagnosed multiple myeloma
View
Georgina Long, ESMO 2022: Highlights in melanoma – SWOG S1801 trial investigating neoadjuvant versus adjuvant pembrolizumab for resected stage III-IV melanoma
View
Emerging data with immunotherapy in esophageal squamous cell carcinoma and potential impact for clinical practice
View
Continuing the momentum in SCLC: Exploring second-line and novel therapy options
View
Treatment decisions in high-risk* acute myeloid leukaemia: what is the ultimate goal?
View
Kim Benstead, European Cancer Summit, 2022: The INTERACT-EUROPE training programme
View
Tailoring the Treatment of Early-stage HER2-positive Breast Cancer: One Size Does Not Fit All
View
Sudeep Gupta, SABCS 2022: Addition of platinum to neoadjuvant chemotherapy in patients with triple-negative breast cancer: A phase III randomized controlled trial
View